Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Arkadiusz Sprawka"'
Autor:
Lucyna Kepka, Dobromira Tyc-Szczepaniak, Krzysztof Bujko, Ewa Wasilewska-Teśluk, Katarzyna Komosinska, Arkadiusz Sprawka, Marta Olszyna-Serementa, Wojciech Michalski, Berenika Trąbska-Kluch, B. Czeremszynska
Publikováno v:
Radiotherapy and Oncology. 121:217-224
Purpose To evaluate if neurological/cognitive function outcomes in patients with resected single brain metastasis (BM) after stereotactic radiotherapy of the tumor bed (SRT-TB) are not inferior compared to those achieved with whole-brain radiotherapy
Autor:
Dobromira Tyc-Szczepaniak, Lucyna Kepka, Berenika Trąbska-Kluch, Arkadiusz Sprawka, Karolina Osowiecka, B. Czeremszynska
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 20(2)
A recent randomized trial (NCT01535209) demonstrated no difference in neurocognitive function between stereotactic radiotherapy of the tumor bed (SRT-TB) and whole brain radiotherapy (WBRT) in patients with resected single brain metastasis. Patients
Autor:
Lucyna Pietrzak, Arkadiusz Sprawka, Krzysztof Bujko, Dobromira Tyc-Szczepaniak, Lucyna Kepka, Dariusz Garmol
Publikováno v:
Acta Oncologica. 52:816-823
To present a retrospective analysis of results of definitive radiotherapy for rectal cancer.Forty-one consecutive patients with rectal cancer (32% primary, 61% pelvic recurrence and 7% after R2 resection) who could not be treated with surgery underwe
Autor:
Lucyna Kepka, Arkadiusz Sprawka, B. Czeremszynska, Dobromira Tyc-Szczepaniak, B. Trabska-Kluch, Marta Olszyna-Serementa, K. Osowiecka
Publikováno v:
Radiotherapy and Oncology. 123:S327-S328
Autor:
Branislav Jeremic, Jai Prakash Agarwal, Francesc Casas, Arkadiusz Sprawka, Sherif Abdel-Wahab, Lucyna Kepka
Publikováno v:
Expert Review of Anticancer Therapy. 9:1379-1387
Thoracic radiotherapy and prophylactic cranial irradiation (PCI) in combination with chemotherapy is an established standard of treatment of limited-disease (LD) small-cell lung cancer (SCLC). Both types of radiotherapy increase 3-year survival by ap
Autor:
Katarzyna Komosinska, Agnieszka Zolciak-Siwinska, Arkadiusz Sprawka, Zuzanna Guzel-Szczepiorkowska, Lucyna Pietrzak, Anna Garbaczewska, Dariusz Garmol, Jakub Palucki, Lucyna Kepka, Krzysztof Bujko
Publikováno v:
Radiotherapy and Oncology. 85:450-455
Purpose To assess the variability among clinicians in the delineation of mediastinal and hilar lymph node stations (LNS) according to the published recommendations in the treatment planning of elective nodal irradiation for lung cancer. Methods Nine
Autor:
Joanna, Socha, Agnieszka, Guzowska, Dobromira, Tyc-Szczepaniak, Marek, Wierzchowski, Arkadiusz, Sprawka, Aleksandra, Szczesna, Lucyna, Kepka
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 20(1)
To compare accelerated hypofractionated (A-HYPO) radiotherapy (RT) with conventionally fractionated (CF) thoracic RT in patients with limited-disease small-cell lung cancer (LD-SCLC).Out of 217 consecutive LD-SCLC patients, treated between 1997 and 2
Autor:
Katarzyna Komosinska, Wojciech Michalski, Ewa Wasilewska-Tesluk, Krzysztof Bujko, B. Czeremszynska, Dobromira Tyc-Szczepaniak, B. Trabska-Kluch, Lucyna Kepka, Arkadiusz Sprawka, Marta Olszyna-Serementa
Publikováno v:
Radiotherapy and Oncology. 119:S160
Autor:
Marta, Olszyna-Serementa, Milena, Kołodziejczyk, Arkadiusz, Sprawka, Anna, Nasierowska-Guttmejer, Krzysztof, Bujko
Publikováno v:
Polish journal of pathology : official journal of the Polish Society of Pathologists. 60(3)
Recently, pathologists have recommended new standards of post operative specimen evaluation in rectal cancer. These new standards include: macroscopic assessment of the quality of surgical excision of mesorectum, microscopic measurement of circumfere
Autor:
Lucyna Kepka, Arkadiusz Sprawka, Francesc Casas, Branislav Jeremic, Jai Prakash Agarwal, Sherif Abdel-Wahab
Publikováno v:
Expert review of anticancer therapy. 9(10)
The combination of radiotherapy and chemotherapy is considered to be a standard approach for patients with locally advanced, stage III non-small-cell lung cancer. The current state of the art of combined radiochemotherapy supported by evidence-based